Silicon Laboratories Inc. (SLAB) stock
Close on Nov 13, 2026Market cap $7.39BP/E –Yield –
Earnings
Silicon Laboratories's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Silicon Laboratories's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Jan 3, 2027 | Feb 3, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Oct 3, 2026 | Nov 10, 2026after the close | $251.00M | +21.8% | $0.26 | $1.05 | Release |
| Q2 FY2026ended Jul 4, 2026 | Aug 11, 2026during market hours | $228.00M | +18.1% | -$0.32 | $0.71 | Release |
| Q1 FY2026ended Apr 4, 2026 | May 5, 2026during market hours | $214.00M | +20.2% | -$0.48 | $0.53 | Release |
| Q4 FY2025ended Jan 3, 2026 | Feb 4, 2026before the open | $208.00M | +25.3% | -$0.08 | $0.56 | Release |
| Q3 FY2025ended Oct 4, 2025 | Nov 4, 2025before the open | $206.00M | +24.1% | -$0.30 | $0.32 | Release |
| Q2 FY2025ended Jul 5, 2025 | Aug 5, 2025before the open | $193.00M | +33.1% | -$0.67 | $0.11 | Release |
| Q1 FY2025ended Apr 5, 2025 | May 13, 2025before the open | $178.00M | +67.9% | -$0.94 | -$0.08 | Release |
| Q4 FY2024ended Dec 28, 2024 | Feb 4, 2025before the open | $166.00M | +90.8% | -$0.73 | -$0.11 | Release |
| Q3 FY2024ended Sep 28, 2024 | Nov 4, 2024during market hours | $166.00M | -18.6% | -$0.88 | -$0.13 | Release |
| Q2 FY2024ended Jun 29, 2024 | Jul 24, 2024before the open | $145.00M | -40.8% | -$2.56 | -$0.56 | Release |
| Q1 FY2024ended Mar 30, 2024 | Apr 24, 2024before the open | $106.00M | -57.1% | -$1.77 | -$0.92 | Release |
| Q4 FY2023ended Dec 30, 2023 | Feb 7, 2024before the open | $87.00M | -66.1% | -$2.19 | -$1.19 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023before the open | $204.00M | -24.4% | $0.32 | $0.62 | Release |
| Q2 FY2023ended Jul 1, 2023 | Jul 26, 2023before the open | $245.00M | -6.8% | $0.33 | $1.04 | Release |
| Q1 FY2023ended Apr 1, 2023 | Apr 26, 2023before the open | $247.00M | +5.6% | $0.41 | $1.12 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 1, 2023before the open | $257.00M | +23.0% | $0.76 | $1.31 | Release |
| Q3 FY2022ended Oct 1, 2022 | Oct 26, 2022before the open | $270.00M | +45.9% | $0.60 | $1.21 | Release |
| Q2 FY2022ended Jul 2, 2022 | Jul 27, 2022before the open | $263.00M | – | $0.60 | $1.17 | Release |
| Q1 FY2022ended Apr 2, 2022 | Apr 27, 2022before the open | $234.00M | – | $0.58 | $1.05 | Release |
| Q4 FY2021ended Jan 1, 2022 | Feb 2, 2022before the open | $209.00M | – | $0.13 | $0.77 | Release |
| Q3 FY2021ended Oct 2, 2021 | Oct 27, 2021before the open | $185.00M | – | -$0.45 | $0.34 | Release |
| Q2 FY2021ended Jul 3, 2021 | Jul 28, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 3, 2021 | Apr 28, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Jan 2, 2021 | Feb 3, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 3, 2020 | Oct 28, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Silicon Laboratories guided for has been reported
Guidance vs results
The last range Silicon Laboratories gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2025 | EPS (GAAP) | -$0.22 – $0.08 | -$0.08 | Within range |
| Q4 FY2025 | Non-GAAP diluted earnings per share | $0.40 – $0.70 | $0.56 | Within range |
| Q4 FY2025 | Revenue | $200.00M – $215.00M | $208.00M | Within range |
| Q3 FY2025 | EPS (GAAP) | -$0.60 – -$0.20 | -$0.30 | Within range |
| Q3 FY2025 | Non-GAAP diluted earnings per share | $0.20 – $0.40 | $0.32 | Within range |
| Q3 FY2025 | Revenue | $200.00M – $210.00M | $206.00M | Within range |
| Q2 FY2025 | EPS (GAAP) | -$0.95 – -$0.55 | -$0.67 | Within range |
| Q2 FY2025 | Non-GAAP diluted earnings (loss) per share | -$0.01 – $0.19 | $0.11 | Within range |
| Q2 FY2025 | Revenue | $185.00M – $200.00M | $193.00M | Within range |
| Q1 FY2025 | EPS (GAAP) | -$1.05 – -$0.75 | -$0.94 | Within range |
| Q1 FY2025 | Non-GAAP diluted earnings (loss) per share | -$0.19 – $0.01 | -$0.08 | Within range |
| Q1 FY2025 | Revenue | $170.00M – $185.00M | $178.00M | Within range |
| Q4 FY2024 | EPS (GAAP) | -$1.05 – -$0.75 | -$0.73 | Above range |
| Q4 FY2024 | Non-GAAP diluted loss per share | -$0.21 – -$0.01 | -$0.11 | Within range |
| Q4 FY2024 | Revenue | $161.00M – $171.00M | $166.00M | Within range |
| Q3 FY2024 | EPS (GAAP) | -$1.25 – -$0.95 | -$0.88 | Above range |
| Q3 FY2024 | Non-GAAP diluted loss per share | -$0.30 – -$0.10 | -$0.13 | Within range |
| Q3 FY2024 | Revenue | $160.00M – $170.00M | $166.00M | Within range |
| Q2 FY2024 | EPS (GAAP) | -$1.61 – -$1.45 | -$2.56 | Below range |
| Q2 FY2024 | Non-GAAP diluted loss per share | -$0.70 – -$0.58 | -$0.56 | Above range |
| Q2 FY2024 | Revenue | $135.00M – $145.00M | $145.00M | Within range |
| Q1 FY2024 | EPS (GAAP) | -$2.05 – -$1.89 | -$1.77 | Above range |
| Q1 FY2024 | Non-GAAP diluted loss per share | -$1.04 – -$0.92 | -$0.92 | Within range |
| Q1 FY2024 | Revenue | $100.00M – $110.00M | $106.00M | Within range |
| Q4 FY2023 | EPS (GAAP) | -$2.39 – -$1.95 | -$2.19 | Within range |
| Q4 FY2023 | Non-GAAP diluted earnings (loss) per share | -$1.66 – -$1.22 | -$1.19 | Above range |
| Q4 FY2023 | Revenue | $70.00M – $100.00M | $87.00M | Within range |
| Q3 FY2023 | EPS (GAAP) | -$0.08 – $0.20 | $0.32 | Above range |
| Q3 FY2023 | Non-GAAP diluted earnings per share | $0.45 – $0.73 | $0.62 | Within range |
| Q3 FY2023 | Revenue | $190.00M – $210.00M | $204.00M | Within range |
| Q2 FY2023 | EPS (GAAP) | $0.35 – $0.45 | $0.33 | Below range |
| Q2 FY2023 | Non-GAAP diluted earnings per share | $0.98 – $1.08 | $1.04 | Within range |
| Q2 FY2023 | Revenue | $238.00M – $248.00M | $245.00M | Within range |
| Q1 FY2023 | EPS (GAAP) | $0.36 – $0.46 | $0.41 | Within range |
| Q1 FY2023 | Non-GAAP diluted earnings per share | $1.07 – $1.17 | $1.12 | Within range |
| Q1 FY2023 | Revenue | $242.00M – $252.00M | $247.00M | Within range |
| Q4 FY2022 | EPS (GAAP) | $0.35 – $0.45 | $0.76 | Above range |
| Q4 FY2022 | Non-GAAP diluted earnings per share | $0.93 – $1.03 | $1.31 | Above range |
| Q4 FY2022 | Revenue | $245.00M – $255.00M | $257.00M | Above range |
| Q3 FY2022 | EPS (GAAP) | $0.49 – $0.59 | $0.60 | Above range |
| Q3 FY2022 | Non-GAAP diluted earnings per share | $1.08 – $1.18 | $1.21 | Above range |
| Q3 FY2022 | Revenue | $265.00M – $275.00M | $270.00M | Within range |
| Q2 FY2022 | EPS (GAAP) | $0.37 – $0.47 | $0.60 | Above range |
| Q2 FY2022 | Non-GAAP diluted earnings per share | $0.85 – $0.95 | $1.17 | Above range |
| Q2 FY2022 | Revenue | $245.00M – $255.00M | $263.00M | Above range |
| Q1 FY2022 | EPS (GAAP) | $0.15 – $0.25 | $0.58 | Above range |
| Q1 FY2022 | Non-GAAP diluted earnings per share | $0.58 – $0.68 | $1.05 | Above range |
| Q1 FY2022 | Revenue | $220.00M – $230.00M | $234.00M | Above range |
| Q4 FY2021 | EPS (GAAP) | -$0.41 – -$0.31 | $0.13 | Above range |
| Q4 FY2021 | Non-GAAP diluted earnings per share | $0.50 – $0.60 | $0.77 | Above range |
| Q4 FY2021 | Revenue | $195.00M – $205.00M | $209.00M | Above range |
Guidance history
Every forecast Silicon Laboratories put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2025 | Non-GAAP diluted earnings per share | Q4 FY2025 | $0.40 – $0.70 | New |
| Nov 4, 2025 | GAAP diluted earnings (loss) per share | Q4 FY2025 | -$0.22 – $0.08 | New |
| Nov 4, 2025 | GAAP gross margin | Q4 FY2025 | 62% – 64% | New |
| Nov 4, 2025 | Non-GAAP gross margin | Q4 FY2025 | 62% – 64% | New |
| Nov 4, 2025 | GAAP operating expenses | Q4 FY2025 | $134.00M – $136.00M | New |
| Nov 4, 2025 | Non-GAAP operating expenses | Q4 FY2025 | $110.00M – $112.00M | New |
| Nov 4, 2025 | revenue | Q4 FY2025 | $200.00M – $215.00M | New |
| Aug 5, 2025 | Non-GAAP diluted earnings per share | Q3 FY2025 | $0.20 – $0.40 | New |
| Aug 5, 2025 | GAAP diluted loss per share | Q3 FY2025 | -$0.60 – -$0.20 | New |
| Aug 5, 2025 | GAAP gross margin | Q3 FY2025 | 57% – 58% | New |
| Aug 5, 2025 | Non-GAAP gross margin | Q3 FY2025 | 57% – 58% | New |
| Aug 5, 2025 | GAAP operating expenses | Q3 FY2025 | $130.00M – $133.00M | New |
| Aug 5, 2025 | Non-GAAP operating expenses | Q3 FY2025 | $107.00M – $110.00M | New |
| Aug 5, 2025 | third-quarter revenue | Q3 FY2025 | $200.00M – $210.00M | New |
| May 13, 2025 | Non-GAAP diluted earnings (loss) per share | Q2 FY2025 | -$0.01 – $0.19 | New |
| May 13, 2025 | GAAP diluted loss per share | Q2 FY2025 | -$0.95 – -$0.55 | New |
| May 13, 2025 | GAAP gross margin | Q2 FY2025 | 55% – 57% | New |
| May 13, 2025 | Non-GAAP gross margin | Q2 FY2025 | 55% – 57% | New |
| May 13, 2025 | GAAP operating expenses | Q2 FY2025 | $129.00M – $131.00M | New |
| May 13, 2025 | Non-GAAP operating expenses | Q2 FY2025 | $106.00M – $108.00M | New |
| May 13, 2025 | second-quarter revenue | Q2 FY2025 | $185.00M – $200.00M | New |
| Feb 4, 2025 | Non-GAAP diluted earnings (loss) per share | Q1 FY2025 | -$0.19 – $0.01 | New |
| Feb 4, 2025 | GAAP diluted loss per share | Q1 FY2025 | -$1.05 – -$0.75 | New |
| Feb 4, 2025 | GAAP gross margin | Q1 FY2025 | 54% – 56% | New |
| Feb 4, 2025 | Non-GAAP gross margin | Q1 FY2025 | 54% – 56% | New |
| Feb 4, 2025 | GAAP operating expenses | Q1 FY2025 | $128.00M – $130.00M | New |
| Feb 4, 2025 | Non-GAAP operating expenses | Q1 FY2025 | $103.00M – $105.00M | New |
| Feb 4, 2025 | first-quarter revenue | Q1 FY2025 | $170.00M – $185.00M | New |
| Nov 4, 2024 | Non-GAAP diluted loss per share | Q4 FY2024 | -$0.21 – -$0.01 | New |
| Nov 4, 2024 | GAAP diluted loss per share | Q4 FY2024 | -$1.05 – -$0.75 | New |
| Nov 4, 2024 | GAAP gross margin | Q4 FY2024 | 54% – 55% | New |
| Nov 4, 2024 | Non-GAAP gross margin | Q4 FY2024 | 54% – 55% | New |
| Nov 4, 2024 | GAAP operating expenses | Q4 FY2024 | $118.00M – $122.00M | New |
| Nov 4, 2024 | Non-GAAP operating expenses | Q4 FY2024 | $97.00M – $99.00M | New |
| Nov 4, 2024 | fourth-quarter revenue | Q4 FY2024 | $161.00M – $171.00M | New |
| Jul 24, 2024 | Non-GAAP diluted loss per share | Q3 FY2024 | -$0.30 – -$0.10 | New |
| Jul 24, 2024 | GAAP diluted loss per share | Q3 FY2024 | -$1.25 – -$0.95 | New |
| Jul 24, 2024 | GAAP gross margin | Q3 FY2024 | 54% – 56% | New |
| Jul 24, 2024 | Non-GAAP gross margin | Q3 FY2024 | 54% – 56% | New |
| Jul 24, 2024 | GAAP operating expenses | Q3 FY2024 | $123.00M – $125.00M | New |
| Jul 24, 2024 | Non-GAAP operating expenses | Q3 FY2024 | $101.00M – $103.00M | New |
| Jul 24, 2024 | revenue | Q3 FY2024 | $160.00M – $170.00M | New |
| Apr 24, 2024 | Non-GAAP diluted loss per share | Q2 FY2024 | -$0.70 – -$0.58 | New |
| Apr 24, 2024 | GAAP diluted loss per share | Q2 FY2024 | -$1.61 – -$1.45 | New |
| Apr 24, 2024 | GAAP gross margin | Q2 FY2024 | 53% | New |
| Apr 24, 2024 | Non-GAAP gross margin | Q2 FY2024 | 53% | New |
| Apr 24, 2024 | GAAP operating expenses | Q2 FY2024 | $125.00M | New |
| Apr 24, 2024 | Non-GAAP operating expenses | Q2 FY2024 | $102.00M | New |
| Apr 24, 2024 | revenue | Q2 FY2024 | $135.00M – $145.00M | New |
| Feb 7, 2024 | Non-GAAP diluted loss per share | Q1 FY2024 | -$1.04 – -$0.92 | New |
| Feb 7, 2024 | GAAP diluted loss per share | Q1 FY2024 | -$2.05 – -$1.89 | New |
| Feb 7, 2024 | GAAP gross margin | Q1 FY2024 | 52% | New |
| Feb 7, 2024 | Non-GAAP gross margin | Q1 FY2024 | 52% | New |
| Feb 7, 2024 | GAAP operating expenses | Q1 FY2024 | $118.00M | New |
| Feb 7, 2024 | Non-GAAP operating expenses | Q1 FY2024 | $96.00M | New |
| Feb 7, 2024 | revenue | Q1 FY2024 | $100.00M – $110.00M | New |
| Nov 1, 2023 | Non-GAAP diluted earnings (loss) per share | Q4 FY2023 | -$1.66 – -$1.22 | New |
| Nov 1, 2023 | GAAP diluted earnings (loss) per share | Q4 FY2023 | -$2.39 – -$1.95 | New |
| Nov 1, 2023 | GAAP gross margin | Q4 FY2023 | 53% | New |
| Nov 1, 2023 | Non-GAAP gross margin | Q4 FY2023 | 53% | New |
| Nov 1, 2023 | GAAP operating expenses | Q4 FY2023 | $123.00M | New |
| Nov 1, 2023 | Non-GAAP operating expenses | Q4 FY2023 | $94.00M | New |
| Nov 1, 2023 | revenue | Q4 FY2023 | $70.00M – $100.00M | New |
| Jul 26, 2023 | Non-GAAP diluted earnings per share | Q3 FY2023 | $0.45 – $0.73 | New |
| Jul 26, 2023 | GAAP diluted earnings (loss) per share | Q3 FY2023 | -$0.08 – $0.20 | New |
| Jul 26, 2023 | GAAP gross margin | Q3 FY2023 | 59% | New |
| Jul 26, 2023 | Non-GAAP gross margin | Q3 FY2023 | 59% | New |
| Jul 26, 2023 | GAAP operating expenses | Q3 FY2023 | $120.00M | New |
| Jul 26, 2023 | Non-GAAP operating expenses | Q3 FY2023 | $95.00M | New |
| Jul 26, 2023 | revenue | Q3 FY2023 | $190.00M – $210.00M | New |
| Apr 26, 2023 | Non-GAAP diluted earnings per share | Q2 FY2023 | $0.98 – $1.08 | New |
| Apr 26, 2023 | GAAP diluted earnings per share | Q2 FY2023 | $0.35 – $0.45 | New |
| Apr 26, 2023 | GAAP gross margin | Q2 FY2023 | 60% | New |
| Apr 26, 2023 | Non-GAAP gross margin | Q2 FY2023 | 60% – 61% | New |
| Apr 26, 2023 | GAAP operating expenses | Q2 FY2023 | $131.00M | New |
| Apr 26, 2023 | GAAP effective tax rate | Q2 FY2023 | 34% | New |
| Apr 26, 2023 | Non-GAAP operating expenses | Q2 FY2023 | $106.00M | New |
| Apr 26, 2023 | Non-GAAP effective tax rate | Q2 FY2023 | 25% | New |
| Apr 26, 2023 | revenue | Q2 FY2023 | $238.00M – $248.00M | New |
| Feb 1, 2023 | Non-GAAP diluted earnings per share | Q1 FY2023 | $1.07 – $1.17 | New |
| Feb 1, 2023 | GAAP diluted earnings per share | Q1 FY2023 | $0.36 – $0.46 | New |
| Feb 1, 2023 | GAAP gross margin | Q1 FY2023 | 63% | New |
| Feb 1, 2023 | Non-GAAP gross margin | Q1 FY2023 | 63% | New |
| Feb 1, 2023 | GAAP effective tax rate | Q1 FY2023 | 31% | New |
| Feb 1, 2023 | Non-GAAP effective tax rate | Q1 FY2023 | 23% | New |
| Feb 1, 2023 | GAAP operating expenses | Q1 FY2023 | $139.00M | New |
| Feb 1, 2023 | Non-GAAP operating expenses | Q1 FY2023 | $111.00M | New |
| Feb 1, 2023 | revenue | Q1 FY2023 | $242.00M – $252.00M | New |
| Oct 26, 2022 | Non-GAAP diluted earnings per share | Q4 FY2022 | $0.93 – $1.03 | New |
| Oct 26, 2022 | GAAP diluted earnings per share | Q4 FY2022 | $0.35 – $0.45 | New |
| Oct 26, 2022 | GAAP gross margin | Q4 FY2022 | 60% | New |
| Oct 26, 2022 | Non-GAAP gross margin | Q4 FY2022 | 60% | New |
| Oct 26, 2022 | GAAP effective tax rate | Q4 FY2022 | 35% | New |
| Oct 26, 2022 | Non-GAAP effective tax rate | Q4 FY2022 | 25% | New |
| Oct 26, 2022 | GAAP operating expenses | Q4 FY2022 | $132.00M | New |
| Oct 26, 2022 | Non-GAAP operating expenses | Q4 FY2022 | $109.00M | New |
| Oct 26, 2022 | revenue | Q4 FY2022 | $245.00M – $255.00M | New |
| Jul 27, 2022 | Non-GAAP diluted earnings per share | Q3 FY2022 | $1.08 – $1.18 | New |
| Jul 27, 2022 | GAAP diluted earnings per share | Q3 FY2022 | $0.49 – $0.59 | New |
| Jul 27, 2022 | GAAP gross margin | Q3 FY2022 | 60% | New |
| Jul 27, 2022 | Non-GAAP gross margin | Q3 FY2022 | 60.5% | New |
| Jul 27, 2022 | GAAP effective tax rate | Q3 FY2022 | 36% | New |
| Jul 27, 2022 | Non-GAAP effective tax rate | Q3 FY2022 | 26% | New |
| Jul 27, 2022 | GAAP operating expenses | Q3 FY2022 | $137.00M | New |
| Jul 27, 2022 | Non-GAAP operating expenses | Q3 FY2022 | $113.00M | New |
| Jul 27, 2022 | revenue | Q3 FY2022 | $265.00M – $275.00M | New |
| Apr 27, 2022 | Non-GAAP diluted earnings per share | Q2 FY2022 | $0.85 – $0.95 | New |
| Apr 27, 2022 | GAAP diluted earnings per share | Q2 FY2022 | $0.37 – $0.47 | New |
| Apr 27, 2022 | GAAP gross margin | Q2 FY2022 | 60.9% | New |
| Apr 27, 2022 | Non-GAAP gross margin | Q2 FY2022 | 61% | New |
| Apr 27, 2022 | GAAP effective tax rate | Q2 FY2022 | 33% | New |
| Apr 27, 2022 | Non-GAAP effective tax rate | Q2 FY2022 | 26% | New |
| Apr 27, 2022 | GAAP operating expenses | Q2 FY2022 | $129.00M | New |
| Apr 27, 2022 | Non-GAAP operating expenses | Q2 FY2022 | $107.00M | New |
| Apr 27, 2022 | revenue | Q2 FY2022 | $245.00M – $255.00M | New |
| Feb 2, 2022 | Non-GAAP diluted earnings per share | Q1 FY2022 | $0.58 – $0.68 | New |
| Feb 2, 2022 | GAAP diluted earnings per share | Q1 FY2022 | $0.15 – $0.25 | New |
| Feb 2, 2022 | GAAP gross margin | Q1 FY2022 | 63% | New |
| Feb 2, 2022 | Non-GAAP gross margin | Q1 FY2022 | 63% | New |
| Feb 2, 2022 | GAAP effective tax rate | Q1 FY2022 | 37% | New |
| Feb 2, 2022 | Non-GAAP effective tax rate | Q1 FY2022 | 30% | New |
| Feb 2, 2022 | GAAP operating expenses | Q1 FY2022 | $128.00M | New |
| Feb 2, 2022 | Non-GAAP operating expenses | Q1 FY2022 | $105.00M | New |
| Feb 2, 2022 | revenue | Q1 FY2022 | $220.00M – $230.00M | New |
| Oct 27, 2021 | Non-GAAP diluted earnings per share | Q4 FY2021 | $0.50 – $0.60 | New |
| Oct 27, 2021 | GAAP diluted loss per share | Q4 FY2021 | -$0.41 – -$0.31 | New |
| Oct 27, 2021 | GAAP gross margin | Q4 FY2021 | 59% | New |
| Oct 27, 2021 | Non-GAAP gross margin | Q4 FY2021 | 59.5% | New |
| Oct 27, 2021 | GAAP effective tax rate | Q4 FY2021 | -14% | New |
| Oct 27, 2021 | Non-GAAP effective tax rate | Q4 FY2021 | 8% | New |
| Oct 27, 2021 | GAAP operating expenses | Q4 FY2021 | $126.00M | New |
| Oct 27, 2021 | Non-GAAP operating expenses | Q4 FY2021 | $95.00M | New |
| Oct 27, 2021 | revenue | Q4 FY2021 | $195.00M – $205.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Silicon Laboratories filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?